nach oben

AIDS and Behavior

Erschienen in:

01.09.2008 | Original Paper

Demographic Characteristics and Sexual Behaviors Associated with Methamphetamine Use among MSM and Non-MSM diagnosed with AIDS in Los Angeles County

verfasst von: Amy Rock Wohl, Douglas M. Frye, Denise F. Johnson

Erschienen in: AIDS and Behavior | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Demographic and behavioral factors associated with methamphetamine use are presented for 455 men who have sex with men (MSM) and 228 non-MSM diagnosed with AIDS in Los Angeles County (LAC) from 2000 to 2004, as there are limited population-based data for these subgroups. Lifetime methamphetamine use was 35% for MSM, 14% for non-MSM, 50% for white MSM, and 35% for black MSM. Methamphetamine use in the previous 12 months among MSM (11%) and non-MSM (0.4%) was less than lifetime use. Compared to MSM with no history of methamphetamine use in a multivariate analysis, MSM methamphetamine users were more likely to be non-Latino (white or black) (OR = 2.8, 95% CI: 1.6, 4.9) compared to Latino and reported ≥10 sexual partners in the previous 12 months (OR = 3.1, 95% CI: 1.7, 5.6). These data indicate that methamphetamine has been widely used by both MSM and non-MSM with AIDS in LAC and that lifetime use is associated with sexual risk behaviors among MSM.

Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. Lancet, 365, 1217–1218.PubMedCrossRef

Bolding, G., Hart, G., Sherr, L., & Elford, J. (2006). Use of crystal methamphetamine among gay men in London. Addiction 101, 1622–1630.PubMedCrossRef

Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., Chesney, M., & Vittinghoff, E. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrate) and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health, 82, i62–i70.PubMed

Collins, R. L., Kanouse, D. E., Gifford, A. L., Senterfitt, J. W., Schuster, M. A., McCaffrey, D. F., Shapiro, M. F., & Wenger, N. S. (2001). Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychology, 20, 351–360.PubMedCrossRef

Diaz, R. M., Heckert, A. L., & Sanchez, J. (2005). Reasons for stimulant use among Latino gay men in San Francisco: A comparison between methamphetamine and cocaine users. Journal of Urban Health, 82, i71–i78.PubMed

Fernandez, M. I., Bowen, G. S., Warren, J. C., Ibanez, G. E., Hernandez, N., Harper, G. W., & Prado, G. (2007). Crystal methamphetamine: A source of added sexual risk for Hispanic men who have sex with men?. Drug and Alcohol Dependence, 86, 245–252.PubMedCrossRef

Frosch, D., Shoptaw, S., Huber, A., Rawson, R. A., & Ling, W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment, 13, 483–486.PubMedCrossRef

Halkitis, P. N., Parsons, J. T., & Stirratt, M. J. (2001). A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41, 17–35.PubMedCrossRef

Halkitis, P. N., Shrem, M. T., & Martin, F. W. (2005a). Sexual behavior patterns of methamphetamine-using gay and bisexual men. Substance Use and Misuse, 40, 703–719.PubMedCrossRef

Halkitis, P. N., Green, K. A., & Mourgues, P. (2005b). Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from project BUMPS. Journal of Urban Health, 82, i18–i125.PubMed

Kall, K. I. (1992). Effects of amphetamine on sexual behavior of male IV drug users in Stockholm—A pilot study. AIDS Education and Prevention, 4, 6–17.PubMed

Kurtz, S. P. (2005). Post-circuit blues: Motivations and consequences of crystal Meth use among gay men in Miami. AIDS and Behavior, 9, 63–72.PubMedCrossRef

Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., Marcotte, T. D., & Masliah, E. (2003). Patterns of selective neuronal damage in Methamphetamine user AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 34, 467–474.PubMedCrossRef

Mansergh, G., Colfax, G. N., Marks, G., Rader, M., Guzman, R., & Buchbinder, S. (2001). The circuit party men’s health survey: Findings and implications for gay and bisexual men. American Journal of Public Health, 91, 953–958.PubMedCrossRef

Molitor, F., Truax, S. R., Ruiz, J. D., & Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine, 168, 93–97.PubMed

Molitor, F., Ruiz, J. D., Flynn, J., Mikanda, J. H., Sun, R. K., Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse, 3, 475–493.CrossRef

Newmeyer, J. A. (2003). Patterns and trends of drug use in the San Francisco Bay area. Journal of Psychoactive Drugs, 35, 127–132.PubMed

Reback, C. J., Larkins, S., & Shoptaw, S. (2004). Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after treatment. AIDS and Behavior, 8, 87–98.PubMedCrossRef

Semple, S. J., Patterson, T. L., & Grant, I. (2004). A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug and Alcohol Dependency, 76, 203–212.CrossRef

Shoptaw, S., Reback, C. J., & Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91–105.PubMedCrossRef

Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., Veniegas, R. C., Freese, T. E., & Hucks-Ortiz, C. (2005) Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78, 125–134.PubMedCrossRef

Shoptaw S. (2006) Methamphetamine use in urban gay and bisexual populations. Topics in HIV Medicine, 14, 84–87.PubMed

Sullivan, P. S., Nakashima, A. K., Purcell, D. W., David, W., & Ward, J. W. (1998). Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: Western United States versus other regions. Journal of Acquired Immune Deficiency Syndromes, 19, 266–273.

Urbina, A., Jones, K. (2004). Crystal methamphetamine, its analogies, and HIV infection: medical and psychiatric aspects of a new epidemic. Clinical Infectious Diseases, 38, 890–894.PubMedCrossRef

Wohl, A. R., Johnson, D. F., Lu, S., Frye, D., Bunch, G., & Simon, P. A. (2004). Recent increase in high-risk sexual behaviors among sexually-active MSM living with AIDS in Los Angeles County. Journal of Acquired Immune Deficiency Syndromes, 35, 209–211.PubMedCrossRef

Wohl A. R., Johnson D. F., Frye D. M. (2007). Increases in non-injection methamphetamine use in men who have sex with men, men who do not have sex with men and Latino men diagnosed with AIDS in Los Angeles County, 2000 through 2004. Journal of Acquired Immune Deficiency Syndromes 45, 601–603.PubMedCrossRef

Titel: Demographic Characteristics and Sexual Behaviors Associated with Methamphetamine Use among MSM and Non-MSM diagnosed with AIDS in Los Angeles County
verfasst von: Amy Rock Wohl
Douglas M. Frye
Denise F. Johnson
Publikationsdatum: 01.09.2008
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 5/2008
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-007-9315-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2008

HIV/AIDS Stigma: Reliability and Validity of a New Measurement Instrument in Chennai, India

Gender, Drug Use, and Perceived Social Support Among HIV Positive Patients

HIV Prevention Altruism and Sexual Risk Behavior in HIV-Positive Men Who Have Sex with Men

Assessing HIV/AIDS Stigma and Discrimination in Developing Countries

Development of Parallel Scales to Measure HIV-Related Stigma

Behavior Surveillance: Prevalence and Factors Associated with High-Risk Sexual Behavior Among HIV-Infected Men in Brazil in the Post-HAART Era